共有 1 页
| 品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
|---|---|---|---|---|---|---|---|
| 罗恩 | R021578-5mg | 5mg | 5~7个工作日 |
S-鲁索替尼 S-Ruxolitinib (INCB018424) |
99% |
|
|
| 罗恩 | R021578-1mg | 1mg | 5~7个工作日 |
S-鲁索替尼 S-Ruxolitinib (INCB018424) |
99% |
|
|
| 罗恩 | R021578-25mg | 25mg | 5~7个工作日 |
S-鲁索替尼 S-Ruxolitinib (INCB018424) |
99% |
|
|
| 罗恩 | R021578-100mg | 100mg | 5~7个工作日 |
S-鲁索替尼 S-Ruxolitinib (INCB018424) |
99% |
|
|
| 阿拉丁 | S129613-5mg | 5mg | 现货 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
Moligand™, ≥98% |
|
|
| 阿拉丁 | S129613-10mg | 10mg | 期货,请咨询 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
Moligand™, ≥98% |
|
|
| 阿拉丁 | S129613-50mg | 50mg | 期货,请咨询 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
Moligand™, ≥98% |
|
|
| 阿拉丁 | S129613-1mg | 1mg | 现货 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
Moligand™, ≥98% |
|
|
| 阿拉丁 | S129613-25mg | 25mg | 期货,请咨询 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
Moligand™, ≥98% |
|
|
| 阿拉丁 | S129613-100mg | 100mg | 期货,请咨询 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
Moligand™, ≥98% |
|
|
| 阿拉丁 | S408648-1ml | 1ml | 现货 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
Moligand™, 10mM in DMSO |
|
|
| 毕得 | BD631043-5mg | 5mg | 现货 |
(S)-3-(4-(7H-吡咯并[2,3-d]嘧啶-4-... (S)-3-(4-(7H-Pyrrolo[2,3-d]p... |
98% |
|
|
| 毕得 | BD631043-1mg | 1mg | 现货 |
(S)-3-(4-(7H-吡咯并[2,3-d]嘧啶-4-... (S)-3-(4-(7H-Pyrrolo[2,3-d]p... |
98% |
|
|
| 毕得 | BD631043-100mg | 100mg | 现货 |
(S)-3-(4-(7H-吡咯并[2,3-d]嘧啶-4-... (S)-3-(4-(7H-Pyrrolo[2,3-d]p... |
98% |
|
|
| 毕得 | BD631043-250mg | 250mg | 现货 |
(S)-3-(4-(7H-吡咯并[2,3-d]嘧啶-4-... (S)-3-(4-(7H-Pyrrolo[2,3-d]p... |
98% |
|
|
| 毕得 | BD631043-50mg | 50mg | 现货 |
(S)-3-(4-(7H-吡咯并[2,3-d]嘧啶-4-... (S)-3-(4-(7H-Pyrrolo[2,3-d]p... |
98% |
|
|
| 毕得 | BD631043-10mg | 10mg | 现货 |
(S)-3-(4-(7H-吡咯并[2,3-d]嘧啶-4-... (S)-3-(4-(7H-Pyrrolo[2,3-d]p... |
98% |
|
|
| 韶远 | SY567271-0.1g | 0.1g | 现货 |
(S)-3-[4-(7H-吡咯并[2,3-d]嘧啶-4-... (S)-3-[4-(7H-Pyrrolo[2,3-d]p... |
>95% |
|
|
| TRC | C988940-25mg | 25mg | 期货,请咨询 |
(S)-Ruxolitinib (3S)-3-Cyclopentyl-3-[4-(7H-... -20度保存 |
|
|
|
| TRC | C988940-50mg | 50mg | 期货,请咨询 |
(S)-Ruxolitinib (3S)-3-Cyclopentyl-3-[4-(7H-... -20度保存 |
|
|
|
| solarbio | IR1020-5mg | 5mg | 请咨询 | S-鲁索替尼 |
|
|
|
| solarbio | IR1020-10mg | 10mg | 请咨询 | S-鲁索替尼 |
|
|
|
| solarbio | IR1020-100mg | 100mg | 请咨询 | S-鲁索替尼 |
|
|
|
| solarbio | IR1020-50mg | 50mg | 请咨询 | S-鲁索替尼 |
|
|
|
| solarbio | IR1020-1mg | 1mg | 请咨询 | S-鲁索替尼 |
|
|
|
| solarbio | IR10201-1ml | 1ml | 请咨询 | S-鲁索替尼(10mM in DMSO,无菌) |
|
|
|
| solarbio | IR10209-1ml | 1ml | 请咨询 | S-鲁索替尼(10mM in DMSO) |
|
|
|
| 安耐吉 | M0149070-100mg | 100mg | 现货 |
(s)-3-(4-(1h-吡咯并[2,3-d]嘧啶-4-... (s)-3-(4-(1h-pyrrolo[2,3-d]p... |
Reference Standards, 98% |
|
|
| 安耐吉 | M0149070-10mg | 10mg | 现货 |
(s)-3-(4-(1h-吡咯并[2,3-d]嘧啶-4-... (s)-3-(4-(1h-pyrrolo[2,3-d]p... |
Reference Standards, 98% |
|
|
| 安耐吉 | M0149070-1mg | 1mg | 现货 |
(s)-3-(4-(1h-吡咯并[2,3-d]嘧啶-4-... (s)-3-(4-(1h-pyrrolo[2,3-d]p... |
Reference Standards, 98% |
|
|
| 安耐吉 | M0149070-50mg | 50mg | 现货 |
(s)-3-(4-(1h-吡咯并[2,3-d]嘧啶-4-... (s)-3-(4-(1h-pyrrolo[2,3-d]p... |
Reference Standards, 98% |
|
|
| 安耐吉 | M0149070-5mg | 5mg | 现货 |
(s)-3-(4-(1h-吡咯并[2,3-d]嘧啶-4-... (s)-3-(4-(1h-pyrrolo[2,3-d]p... |
Reference Standards, 98% |
|
|
| 源叶 | S81142-5mg | 5mg | 现货 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
≥98% |
|
|
| 源叶 | S81142-1mg | 1mg | 现货 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
≥98% |
|
|
| 源叶 | S81142-10mg | 10mg | 现货 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
≥98% |
|
|
| 源叶 | S81142-25mg | 25mg | 现货 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
≥98% |
|
|
| 源叶 | S81142-50mg | 50mg | 现货 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
≥98% |
|
|
| 源叶 | S81142-100mg | 100mg | 现货 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
≥98% |
|
|
| 源叶 | S59581-1ml | 1ml | 现货 |
鲁索替尼 S-Ruxolitinib (INCB018424) |
10mM in DMSO |
|
|
| Target Mol | T6156-5mg | 5 mg | 现货 |
环丙基[4-[3-(1H-咪唑-5-基)丙氧基]苯 Ruxolitinib (S enantiomer) |
99.79% |
|
|
| Target Mol | T6156-10mg | 10 mg | 现货 |
环丙基[4-[3-(1H-咪唑-5-基)丙氧基]苯 Ruxolitinib (S enantiomer) |
99.79% |
|
|
| Target Mol | T6156-50mg | 50 mg | 现货 |
环丙基[4-[3-(1H-咪唑-5-基)丙氧基]苯 Ruxolitinib (S enantiomer) |
99.79% |
|
|
| Target Mol | T6156-100mg | 100 mg | 现货 |
环丙基[4-[3-(1H-咪唑-5-基)丙氧基]苯 Ruxolitinib (S enantiomer) |
99.79% |
|
|
| Target Mol | T6156-1mLx10mM(inDMSO) | 1 mL x 10 mM (in DMSO) | 现货 |
环丙基[4-[3-(1H-咪唑-5-基)丙氧基]苯 Ruxolitinib (S enantiomer) |
99.79% |
|
|
| QCC | QR241201 | 100mg | 4-6周 |
Ruxolitinib Impurity A Ruxolitinib Impurity A |
咨询 | 请联系客服购买! | |
| MCE | HY-50856A-100mg | 100mg | 现货 |
Ruxolitinib (S enantiomer) Ruxolitinib (S enantiomer) |
99.77% |
|
|
| MCE | HY-50856A-50mg | 50mg | 现货 |
Ruxolitinib (S enantiomer) Ruxolitinib (S enantiomer) |
99.77% |
|
|
| MCE | HY-50856A-10mg | 10mg | 现货 |
Ruxolitinib (S enantiomer) Ruxolitinib (S enantiomer) |
99.77% |
|
|
| MCE | HY-50856A-10mM*1mL | 10mM*1mL | 现货 |
Ruxolitinib (S enantiomer) Ruxolitinib (S enantiomer) |
99.77% |
|
|
| MCE | HY-50856A-5mg | 5mg | 现货 |
Ruxolitinib (S enantiomer) Ruxolitinib (S enantiomer) |
99.77% |
|
|
| MCE | HY-50856A-1mg | 1mg | 现货 |
Ruxolitinib (S enantiomer) Ruxolitinib (S enantiomer) |
99.77% |
|
|